Finnish pharma to treat cocaine-dependent US veterans?
Monday, 16 January 2012
Finnish pharma company Biotie Therapies is launching a drug trial in
the US investigating the treatment of cocaine dependence. The
multi-million dollar study is funded by the US Department of Defence,
which is looking to remedy drug dependence among its veterans returning
from Iraq and Afghanistan.
researchers are hoping nepicastat, a dopamine inhibitor, will be a
magic bullet for treating both cocaine dependence and post-traumatic
stress disorder (PTSD).
“Among returning veterans, the drug problem is even worse than during
the Vietnam war,” says Biotie chief executive Timo Veromaa.
Nepicastat, a synthetic drug administered as an oral tablet, is being
tested at a dozen substance abuse treatment centres across the United
“PTSD is very difficult to treat and psychotherapy doesn’t always help,” says Veromaa.
It can take years for a new drug to come through the pipeline. That
said, it could be years before the drug reaches pharmacy shelves.
News Source: Finnish Yle